New TB vaccine in 100 years advances as Wellcome, Gates Foundation fund trial

Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical…